Matteo Simonelli

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

Cancers

Neuro-oncology advances

Journal of clinical medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Humanitas University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Humanitas University Apr 01 2017

Italy

Assistant Professor in Medical Oncology :: Department of Biomedical Sciences

Humanitas Cancer Center - Humanitas Research Hospital Sep 01 2014

Italy

Senior Clinical and Research Physician :: Medical Oncology

Publications

Agnese Losurdo, Antonio Di Muzio, Beatrice Claudia Cianciotti, Angelo Dipasquale, Pasquale Persico, Chiara Barigazzi, Beatrice Claudia Bono, Simona Feno, Federico Pessina, Armando Santoro, Matteo Simonelli
T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression. Cancers 16 (3) (2024)
Agnese Losurdo, Antonio Di Muzio, Beatrice Claudia Cianciotti, Angelo Dipasquale, Pasquale Persico, Chiara Barigazzi, Beatrice Claudia Bono, Simona Feno, Federico Pessina, Armando Santoro, Matteo Simonelli
T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression. Cancers 16 (3) (2024)
Angelo Dipasquale, Enrico Franceschi, Giuseppe Lombardi, Matteo Simonelli
Vorasidenib in IDH mutant WHO grade 2 gliomas: time to stop sitting on the fence? Neuro-oncology advances 6 (1) (2024)
Angelo Dipasquale, Enrico Franceschi, Giuseppe Lombardi, Matteo Simonelli
Vorasidenib in IDH mutant WHO grade 2 gliomas: time to stop sitting on the fence? Neuro-oncology advances 6 (1) (2024)
Francesca Orzan, Francesca De Bacco, Elisabetta Lazzarini, Giovanni Crisafulli, Alessandra Gasparini, Angelo Dipasquale, Ludovic Barault, Marco Macagno, Pasquale Persico, Federico Pessina, Beatrice Claudia Bono, Laura Giordano, Pietro Zeppa, Antonio Melcarne, Paola Cassoni, Diego Garbossa, Armando Santoro, Paolo Maria Comoglio, Stefano Indraccolo, Matteo Simonelli, Carla Boccaccio
Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Pasquale Persico, Elena Lorenzi, Agnese Losurdo, Angelo Dipasquale, Antonio Di Muzio, Pierina Navarria, Federico Pessina, Letterio Salvatore Politi, Giuseppe Lombardi, Armando Santoro, Matteo Simonelli
Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations. Cancers 14 (5) (2022)
Mario Caccese, Matteo Simonelli, Veronica Villani, Simona Rizzato, Tamara Ius, Francesco Pasqualetti, Marco Russo, Roberta Rudà, Rosina Amoroso, Luisa Bellu, Roberta Bertorelle, Francesco Cavallin, Angelo Dipasquale, Mariantonia Carosi, Stefano Pizzolitto, Daniela Cesselli, Pasquale Persico, Beatrice Casini, Angelo Paolo Dei Tos, Vittorina Zagonel, Giuseppe Lombardi
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study. Cancers 14 (10) (2022)
Maria Vieito, Matteo Simonelli, Filip de Vos, Victor Moreno, Marjolein Geurts, Elena Lorenzi, Marina Macchini, Martin J Van Den Bent, Gianluca Del Conte, Maja de Jonge, Maria Cruz Martín-Soberón, Barbara Amoroso, Tania Sanchez-Perez, Marlene Zuraek, Bishoy Hanna, Ida Aronchik, Ellen Filvaroff, Henry Chang, Cristina Mendez, Marina Arias Parro, Xin Wei, Zariana Nikolova, Juan Manuel Sepulveda
Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma. Neuro-oncology advances 4 (1) (2022)
David A Reardon, Tae Min Kim, Jean-Sebastien Frenel, Matteo Simonelli, Juanita Lopez, Deepa S Subramaniam, Lillian L Siu, Hui Wang, Suba Krishnan, Karen Stein, Christophe Massard
Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial. Cancer 127 (10) (2021)
Giuseppe Lombardi, Alessandro Della Puppa, Marco Pizzi, Giulia Cerretti, Camilla Bonaudo, Marina Paola Gardiman, Angelo Dipasquale, Fabiana Gregucci, Alice Esposito, Debora De Bartolo, Vittorina Zagonel, Matteo Simonelli, Alba Fiorentino, Francois Ducray
An Overview of Intracranial Ependymomas in Adults. Cancers 13 (23) (2021)
Matteo Simonelli, Pasquale Persico, Arianna Capucetti, Claudia Carenza, Sara Franzese, Elena Lorenzi, Angelo Dipasquale, Agnese Losurdo, Laura Giordano, Federico Pessina, Pierina Navarria, Letterio S Politi, Domenico Mavilio, Massimo Locati, Silvia Della Bella, Armando Santoro, Raffaella Bonecchi
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes. Neuro-oncology advances 3 (1) (2021)
Marta Padovan, Marica Eoli, Alessia Pellerino, Simona Rizzato, Claudia Caserta, Matteo Simonelli, Maria Michiara, Mario Caccese, Elena Anghileri, Giulia Cerretti, Roberta Rudà, Vittorina Zagonel, Giuseppe Lombardi
Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO). Cancers 13 (11) (2021)
Pasquale Persico, Elena Lorenzi, Angelo Dipasquale, Federico Pessina, Pierina Navarria, Letterio Salvatore Politi, Armando Santoro, Matteo Simonelli
Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives. Journal of clinical medicine 10 (7) (2021)
Federico Pessina, Pierina Navarria, Elena Clerici, Luisa Bellu, Andrea Franzini, Davide Milani, Matteo Simonelli, Pasquale Persico, Letterio Salvatore Politi, Alessandra Casarotti, Bethania Fernades, Simone Olei, Martina Sollini, Arturo Chiti, Marta Scorsetti
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study. Journal of clinical medicine 10 (11) (2021)
Timothy Anthony Yap, Maria Vieito, Capucine Baldini, Juan Manuel Sepúlveda-Sánchez, Shunsuke Kondo, Matteo Simonelli, Rasha Cosman, Andre van der Westhuizen, Victoria Atkinson, Antoine F Carpentier, Mario Löhr, Rebecca Redman, Warren Mason, Andres Cervantes, Emilie Le Rhun, Sebastian Ochsenreither, Louise Warren, Yumin Zhao, Sophie Callies, Shawn T Estrem, Michael Man, Leena Gandhi, Emin Avsar, Davide Melisi
First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Mario Caccese, Tamara Ius, Matteo Simonelli, Angelo Paolo Dei Tos, Daniela Cesselli, Angelo Dipasquale, Francesco Cavallin, Marta Padovan, Alessandro Salvalaggio, Marina Paola Gardiman, Miran Skrap, Vittorina Zagonel, Giuseppe Lombardi
Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study. International journal of molecular sciences 21 (18) (2020)
Giuseppe Lombardi, Valeria Barresi, Stefano Indraccolo, Michele Simbolo, Angelo Paolo Dei Tos, Susanna Mandruzzato, Matteo Simonelli, Mario Caccese, Marco Pizzi, Arianna Fassina, Marta Padovan, Elena Masetto, Marina Paola Gardiman, Maria Giuseppina Bonavina, Maria Caffo, Pasquale Persico, Franco Chioffi, Luca Denaro, Angelo Paolo Dei Tos, Aldo Scarpa, Vittorina Zagonel
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study. Cancers 12 (8) (2020)

Matteo Simonelli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matteo Simonelli